Showing results (671-680 of 1,120) with videos related to

Sort By:
Pageof 112
Circulation. Cardiovascular Interventions|December 17, 2021
Ischemic Events Occur Early in Patients Undergoing Percutaneous Coronary Intervention and Are Reduced With Cangrelor: Findings From CHAMPION PHOENIXMatthew A Cavender, Robert A Harrington, Gregg W Stone, et al.
American Heart Journal|April 30, 2017
Balancing the risk of spontaneous ischemic and major bleeding events in acute coronary syndromesGregory Ducrocq, Phillip J Schulte, Andrzej Budaj, et al.
Arquivos Brasileiros De Cardiologia|April 5, 2023
Rivaroxaban in Outpatients with Mild or Moderate COVID-19: Rationale and Design of the Study CARE (CARE - Coalition COVID-19 Brazil VIII)Gustavo B F Oliveira, Precil Diego M M Neves, Haliton A Oliveira, et al.
American Heart Journal Plus : Cardiology Research and Practice|March 29, 2024
Efficacy and safety of cangrelor in patients with peripheral artery disease undergoing percutaneous coronary intervention - Insights from the CHAMPION programJ Antonio Gutierrez, Robert A Harrington, Gregg W Stone, et al.
Kidney360|June 20, 2022
Challenges of Conducting Clinical Trials during the SARS-CoV-2 Pandemic: The ASCEND Global Program ExperienceKirsten L Johansen, Anjali Acharya, Borut Cizman, et al.
Circulation. Cardiovascular Interventions|February 24, 2022
Effect of Platelet Inhibition by Cangrelor Among Obese Patients Undergoing Coronary Stenting: Insights From CHAMPIONBenjamin E Peterson, Robert A Harrington, Gregg W Stone, et al.
American Heart Journal|June 19, 2018
Discharge timing and outcomes after uncomplicated non-ST-segment elevation acute myocardial infarctionJennifer A Rymer, Michael W Tempelhof, Robert M Clare, et al.
JACC. Heart Failure|March 14, 2014
Heart failure complicating non-ST-segment elevation acute coronary syndrome: timing, predictors, and clinical outcomesMaria Cecilia Bahit, Renato D Lopes, Robert M Clare, et al.
Pageof 112